Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
This is an increase over the number of companies cited in the previous month.
The citations in the county include:
- You did not develop an FSVP.
- After you determined that concerns associated with importing a food from a foreign supplier changed, you did not promptly determine and document whether it is appropriate to continue to import the food from the foreign supplier.
- You did not document that you promptly reevaluated a foreign supplier's performance or the risk posed by a food when you became aware of new information about the foreign supplier's performance or the risk posed by a food.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
JMD, LLC | Food and Cosmetics | 02/21/2025 | Develop FSVP |
JMD, LLC | Food and Cosmetics | 02/21/2025 | Continue to import, change activities |
JMD, LLC | Food and Cosmetics | 02/21/2025 | Revaluate - new information |
JMD, LLC | Food and Cosmetics | 02/21/2025 | Corrective actions - take, document |
JMD, LLC | Food and Cosmetics | 02/21/2025 | Investigate |